• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress.LINC00958 通过海绵吸附 miR-625-5p 抑制膀胱癌细胞自噬,促进肿瘤血管生成和氧化应激。
Oxid Med Cell Longev. 2022 Oct 10;2022:2435114. doi: 10.1155/2022/2435114. eCollection 2022.
2
Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through Signaling Pathway.高表达的 LINC00958 通过信号通路调节膀胱癌细胞的生长和上皮-间充质转化。
Cancer Biother Radiopharm. 2023 Aug;38(6):405-414. doi: 10.1089/cbr.2022.0005. Epub 2022 Jun 29.
3
Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.长链非编码 RNA LINC00958 通过作为 microRNA-330-5p 的海绵来下调 PAX8 从而防止胰腺癌的肿瘤发生。
Cancer Lett. 2019 Apr 1;446:49-61. doi: 10.1016/j.canlet.2018.12.017. Epub 2019 Jan 9.
4
Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.环状 RNA 0058063 通过海绵吸附 miR-145-5p 调控 CDK6 促进膀胱癌进展。
J Cell Physiol. 2019 Apr;234(4):4812-4824. doi: 10.1002/jcp.27280. Epub 2018 Oct 26.
5
Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.抑癌 microRNA-139-5p 通过靶向连接蛋白 43 抑制膀胱癌细胞系 ECV-304 的特性。
Chin Med J (Engl). 2019 Oct 5;132(19):2354-2361. doi: 10.1097/CM9.0000000000000455.
6
[Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells].[长链非编码RNA-UCA1靶向微小RNA-204-5p对子宫内膜癌细胞增殖、迁移、凋亡及免疫逃逸的影响]
Zhonghua Zhong Liu Za Zhi. 2023 Jan 23;45(1):56-63. doi: 10.3760/cma.j.cn112152-20200623-00588.
7
linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer.linc00958/miR-185-5p/RSF-1 通过 AKT1/GSK3β/VEGFA 通路调节宫颈癌顺铂耐药和血管生成。
Reprod Biol Endocrinol. 2022 Sep 2;20(1):132. doi: 10.1186/s12958-022-00995-2.
8
LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.长链非编码 RNA SNHG6 通过靶向 miR-26b-5p 调控 Hedgehog 信号通路并影响胆囊癌细胞的生物学功能。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7598-7611. doi: 10.26355/eurrev_202007_22258.
9
LINC00958 promotes endometrial cancer cell proliferation and metastasis by regulating the miR-145-3p/TCF4 axis.LINC00958 通过调控 miR-145-3p/TCF4 轴促进子宫内膜癌细胞的增殖和转移。
J Gene Med. 2021 Jul;23(7):e3345. doi: 10.1002/jgm.3345. Epub 2021 May 11.
10
Long non-coding RNA LINC00958 promotes colorectal cancer progression by enhancing the expression of LEM domain containing 1 via microRNA miR-3064-5p.长链非编码 RNA LINC00958 通过增强含有 LEM 结构域的 1 蛋白表达促进结直肠癌进展。
Bioengineered. 2021 Dec;12(1):8100-8115. doi: 10.1080/21655979.2021.1985259.

引用本文的文献

1
Exploring the microRNA-mRNA regulatory network associated with solasonine in bladder cancer.探索与膀胱癌中茄碱相关的微小RNA-信使核糖核酸调控网络。
Transl Androl Urol. 2024 May 31;13(5):812-827. doi: 10.21037/tau-23-469. Epub 2024 May 27.
2
The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications.长链非编码RNA在卵巢癌中的作用:从功能到治疗意义
Front Oncol. 2024 Apr 25;14:1332528. doi: 10.3389/fonc.2024.1332528. eCollection 2024.
3
Retracted: LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress.撤回:LINC00958通过海绵吸附miR-625-5p抑制膀胱癌细胞自噬以促进肿瘤血管生成和氧化应激
Oxid Med Cell Longev. 2023 Jun 21;2023:9812826. doi: 10.1155/2023/9812826. eCollection 2023.
4
An Overview of Angiogenesis in Bladder Cancer.膀胱癌中的血管生成概述。
Curr Oncol Rep. 2023 Jul;25(7):709-728. doi: 10.1007/s11912-023-01421-5. Epub 2023 Apr 13.
5
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics.靶向自噬作用的长链非编码 RNA(lncRNAs):癌症治疗领域的新领域。
Cells. 2023 Mar 6;12(5):810. doi: 10.3390/cells12050810.
6
The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer.小核仁RNA(snoRNA)和长链非编码RNA(lincRNA)在膀胱癌中的诊断和治疗作用
Cancers (Basel). 2023 Feb 4;15(4):1007. doi: 10.3390/cancers15041007.

本文引用的文献

1
Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through Signaling Pathway.高表达的 LINC00958 通过信号通路调节膀胱癌细胞的生长和上皮-间充质转化。
Cancer Biother Radiopharm. 2023 Aug;38(6):405-414. doi: 10.1089/cbr.2022.0005. Epub 2022 Jun 29.
2
Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer.miR-625-5p 和 miR-874-3p 在去势抵抗性前列腺癌进展中的功能作用。
Life Sci. 2022 Jul 15;301:120603. doi: 10.1016/j.lfs.2022.120603. Epub 2022 May 1.
3
Placental transcriptome sequencing combined with bioinformatics predicts potential genes and circular RNAs associated with hemoglobin Bart's hydrops fetalis syndrome.胎盘转录组测序结合生物信息学预测与巴氏水肿胎儿综合征相关的潜在基因和环状RNA。
J Obstet Gynaecol Res. 2022 Feb;48(2):313-327. doi: 10.1111/jog.15126. Epub 2021 Dec 21.
4
LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA.LINC00958 通过靶向 miR-490-3p 和 AURKA 促进膀胱癌发生。
BMC Cancer. 2021 Oct 26;21(1):1145. doi: 10.1186/s12885-021-08882-6.
5
RBM24 exacerbates bladder cancer progression by forming a Runx1t1/TCF4/miR-625-5p feedback loop.RBM24 通过形成 Runx1t1/TCF4/miR-625-5p 反馈环促进膀胱癌进展。
Exp Mol Med. 2021 May;53(5):933-946. doi: 10.1038/s12276-021-00623-w. Epub 2021 May 21.
6
Oxidative stress and its role in cancer.氧化应激及其在癌症中的作用。
J Cancer Res Ther. 2021 Jan-Mar;17(1):22-28. doi: 10.4103/jcrt.JCRT_862_16.
7
LNCcation: lncRNA localization and function.定位:长链非编码 RNA 的定位和功能。
J Cell Biol. 2021 Feb 1;220(2). doi: 10.1083/jcb.202009045.
8
Optimal scanning concentration of MR imaging for tumor-bearing nude mice with SPIO-shRNA molecular probe.载超顺磁性氧化铁纳米颗粒短发夹 RNA 分子探针的荷瘤裸鼠 MRI 最佳扫描浓度。
Sci Rep. 2020 Oct 29;10(1):18655. doi: 10.1038/s41598-020-73923-2.
9
Contrast effects of autophagy in the treatment of bladder cancer.自噬在膀胱癌治疗中的对比作用。
Exp Biol Med (Maywood). 2021 Feb;246(3):354-367. doi: 10.1177/1535370220959336. Epub 2020 Sep 20.
10
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.RNA 药物和小分子的 RNA 靶点:原理、进展与挑战。
Pharmacol Rev. 2020 Oct;72(4):862-898. doi: 10.1124/pr.120.019554.

LINC00958 通过海绵吸附 miR-625-5p 抑制膀胱癌细胞自噬,促进肿瘤血管生成和氧化应激。

LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress.

机构信息

Department of Urological Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.

School of Medicine, Nantong University, Nantong, Jiangsu 226001, China.

出版信息

Oxid Med Cell Longev. 2022 Oct 10;2022:2435114. doi: 10.1155/2022/2435114. eCollection 2022.

DOI:10.1155/2022/2435114
PMID:36262285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9576423/
Abstract

OBJECTIVE

This study further explored LINC00958's role in promoting tumor angiogenesis (AG) and oxidative stress (OS) development by inhibiting BC cell autophagy through sponge adsorption of miR-625-5p.

METHODS

BC patients and healthy controls who visited our hospital between June 2017 and February 2019 were selected as the research group (RG) and the control group (CG), respectively, with a total of 133 study subjects. Peripheral blood LINC00958 and miR-625-5p in both cohorts of participants were detected. Additionally, human bladder transitional cell carcinoma cells (T24 and J82) and human normal urothelial cells (SV-HUC-1) were purchased. Alterations in cell biological behavior were observed after transfecting miR-625-5p-mimics, miR-625-5p-inhibition, and miR-625-5p-NC sequences into these cells, respectively. Besides, ELISA was performed to quantify inflammatory factors (IFs), AG indicators, and OS indexes in cells. Subsequently, a double luciferase reporter (DLR) assay was performed to verify the targeting relationship between LINC00958 and miR-625-5p. Finally, BALB/c-nu nude mice were purchased, and T24 cells transfected with silenced LINC00958 and miR-625-5p expression sequences were used to establish subcutaneous tumors to observe tumor growth and pathological changes.

RESULTS

RG exhibited higher LINC00958 and lower miR-625-5p than CG. LINC00958 and miR-625-5p were strongly linked to myometrial invasion (MI), lymph node metastasis (LNM), distant metastasis (DM), and histology in BC patients, and the increase of LINC00958 and the decrease of miR-625-5p predicted an increased risk of prognostic death in such patients. After miR-625-5p inhibition, the capacity of BC cells to proliferate, invade, and migrate enhanced and the AG, inflammatory response, and OS injury increased, while the apoptosis rate and autophagy ability decreased. The DLR assay revealed inhibited LINC00958WT fluorescence activity by miR-625-5p-mimics, while the biological behavior of BC cells cotransfected with sh-LINC00958 and miR-625-5p-inhibition had no difference with the functions of sh-control and miR-625-5p-NC cotransfected cells. Finally, the nude mouse tumorigenesis experiment showed that the tumor mass, volume, and histopathological features of the sh-LINC00958 group were decreased compared with the sh-control group, while those of the miR-625-5p-inhibition group were increased versus miR-625-5p-NC.

CONCLUSIONS

In BC, LINC00958 is highly expressed while miR-625-5p is underexpressed. LINC00958 can inhibit cell autophagy to enhance cell activity; promote OS, inflammation, and AG; and regulate tumor immunity by targeting miR-625-5p, thus participating in the development of BC.

摘要

目的

本研究通过海绵吸附 miR-625-5p 抑制 BC 细胞自噬,进一步探讨 LINC00958 通过抑制 miR-625-5p 促进肿瘤血管生成 (AG) 和氧化应激 (OS) 发展的作用。

方法

选择 2017 年 6 月至 2019 年 2 月期间我院就诊的 BC 患者和健康对照者分别作为研究组 (RG) 和对照组 (CG),共纳入 133 例研究对象。检测两组参与者的外周血 LINC00958 和 miR-625-5p。此外,还购买了人膀胱移行细胞癌细胞 (T24 和 J82) 和人正常尿路上皮细胞 (SV-HUC-1)。分别转染 miR-625-5p-模拟物、miR-625-5p 抑制物和 miR-625-5p-NC 序列后观察这些细胞的细胞生物学行为变化。此外,采用 ELISA 法测定细胞中炎症因子 (IFs)、AG 指标和 OS 指标。随后,进行双荧光素酶报告 (DLR) 检测验证 LINC00958 和 miR-625-5p 之间的靶向关系。最后,购买 BALB/c-nu 裸鼠,将沉默 LINC00958 和 miR-625-5p 表达序列的 T24 细胞转染用于建立皮下肿瘤,观察肿瘤生长和病理变化。

结果

RG 组的 LINC00958 高于 CG 组,miR-625-5p 低于 CG 组。LINC00958 和 miR-625-5p 与 BC 患者的肌层浸润 (MI)、淋巴结转移 (LNM)、远处转移 (DM) 和组织学密切相关,LINC00958 的增加和 miR-625-5p 的减少预示着此类患者预后死亡风险增加。抑制 miR-625-5p 后,BC 细胞的增殖、侵袭和迁移能力增强,AG、炎症反应和 OS 损伤增加,而细胞凋亡率和自噬能力下降。DLR 检测显示 miR-625-5p-模拟物抑制了 LINC00958WT 的荧光活性,而共转染 sh-LINC00958 和 miR-625-5p 抑制物的 BC 细胞的生物学行为与共转染 sh 对照和 miR-625-5p-NC 的细胞的功能没有差异。最后,裸鼠肿瘤发生实验显示,与 sh 对照相比,sh-LINC00958 组的肿瘤质量、体积和组织病理学特征减少,而 miR-625-5p 抑制组的肿瘤质量、体积和组织病理学特征增加。

结论

在 BC 中,LINC00958 高表达而 miR-625-5p 低表达。LINC00958 可通过抑制细胞自噬来增强细胞活性;促进 OS、炎症和 AG;并通过靶向 miR-625-5p 调节肿瘤免疫,从而参与 BC 的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/30ec27aaf05c/OMCL2022-2435114.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/0cbf08995f3a/OMCL2022-2435114.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/a1f7cbebbc29/OMCL2022-2435114.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/fe2848bece09/OMCL2022-2435114.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/ccf1c0004181/OMCL2022-2435114.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/6839d56d8741/OMCL2022-2435114.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/61a8b5633ac1/OMCL2022-2435114.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/1c4c2e5d64c3/OMCL2022-2435114.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/30ec27aaf05c/OMCL2022-2435114.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/0cbf08995f3a/OMCL2022-2435114.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/a1f7cbebbc29/OMCL2022-2435114.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/fe2848bece09/OMCL2022-2435114.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/ccf1c0004181/OMCL2022-2435114.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/6839d56d8741/OMCL2022-2435114.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/61a8b5633ac1/OMCL2022-2435114.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/1c4c2e5d64c3/OMCL2022-2435114.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/9576423/30ec27aaf05c/OMCL2022-2435114.008.jpg